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ABSTRACT
Electrical potentials have been recorded by surface Evoked Potentials namely the Somatosensory Evoked Potential,
Auditory Brainstem Response and Visual Evoked Potential [VEP]. Visual conduction disturbance can be evaluated
by these instruments. A mass response of cortical and possibly subcortical may be represented, visual areas to visual
stimuli. Diabetic patients without a past history of cerebrovascular accidents diagnosed with Non- Proliferative
Diabetic retinopathy[DR] with a best corrected visual acuity at least 6/9.This study was done to assess whether a
delay in VEP latency observed in diagnosed type II DM patients could be ascribed to dysfunction of the retinal or
post retinal structures or by both. It is to find out whether the VEP latencies are altered in diabetes or not, if altered
and to correlate duration of the diabetes mellitus with visual evoked potential changes.  Visual evoked potentials are
useful as a non invasive investigatory method in establishing central nervous system neuropathy developing in
diabetes. This study clearly shows that changes in VEP may be detected in diabetics before the onset of retinopathy.
Future  studies  should  be  focused  on  evaluation  of  the  time  that  elapses  between  the  appearance  of  the  first
detectable pathologic electrophysiologic changes and the first ophthalmoscopically detectable retinal changes in
patients with Diabetes Mellitus [DM].
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INTRODUCTION
Electrical  potentials  that  occur  in  the  cortex  after
stimulation of a sense organ, which can be recorded by
surface  electrodes,  are  known  as  Evoked Potentials
[EP].  e.g.  Somatosensory  Evoked  Potential  (SEP),
Auditory  Brainstem  Response  (ABR)  and  Visual
Evoked Potential (VEP).
A  change  has  been  observed  over  time  with  the
clinical  use  of  Electric  potentials.  There  have  been
advances  in  imaging  technology,  especially  in
magnetic resonance imaging (MRI), have reduced the
use  of  EP  testing  in  clinical  practice.  MRI  largely
remains an imaging, structural, or anatomic test and
therefore  gives  more  accurate  information  about
structural problems. EP testing assesses functionality
and thus supplies information about the physiology of
a  certain  anatomic  pathway,  providing  much  less
spatial or localizing information than MRI does.
1
These electric potentials are used in the detection of
anterior visual  conduction  disturbance.  A  mass
response of cortical and possibly subcortical may be
represented,  visual  areas  to  visual  stimuli.
2,3 VEP
affection is related to age of onset of diabetes and
glycemic control. Any abnormalities in the visual
pathway  can  be  detected  with  the  help  of  VEP
much prior to appearance of visual symptoms or
changes in fundus examination.
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These equipments  permit  one  sectioning of
structures which help in visual pathway neural
conduction.
5 Evaluation of bioelectric activity of
the  retinal  layers  is  done  with  the  help  of
electroretinographic
signals with  patterned stimuli (PERG)
6.
The aim of this study is to evaluate the visual pathway
abnormalities in diabetic patients without retinopathy
and with non-prolierative diabetic retinopathy (NPDR)
and  to  determine  abnormal  frequency  and  to
investigate  the  relationship  between  other  variables
such as duration of diabetes and degree of metabolic
control.
Fig 1: Visual evoked potential
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Aim & Objectives
Aim: Aim of this work is to assess whether a delay
in  VEP  latency  observed  in  diagnosed  type  II  DM
patients could be ascribed to dysfunction of the retinal
or post retinal structures or by both.
Objectives: 1. To find whether the VEP-PR latencies
are altered in diabetes or not. 2. To correlate duration
of the diabetes mellitus with visual evoked potential
changes.
MATERIALS AND METHODS
Experimental design: A cross sectional study.
Subjects: Patients were selected from the outpatient
of Ophthalmology Department of Meenakshi Medical
College  &  Hospital,  Kanchipuram . An  informed
consent  and  ethical  committee  clearance  have  been
taken for this study.
Inclusion criteria:
1. No past history of cerebrovascular accidents
2. Diabetic patients with duration of 1-10 years.
3. Non- Proliferative Diabetic retinopathy
4. Best corrected visual acuity at least 6/9
Exclusion criteria:
1. Cataract, 2. Glaucoma 3. Vitreous opacities or
any  evidence  of  optic  atrophy 4. Peripheral  nervous
system disease 5. Proliferative diabetic retinopathy
General examination and systemic examination:
General examination was done in the Department of
Ophthalmology  and  a  detailed  history  of
Cerebrovascular  diseases,  Cataract,  Glaucoma,  any
Optic nerve pathology and TB was taken.
Visual  evoked  potentials  were  recorded  using
pattern reversal stimulation
Study  Group: The  study  groups  were  divided  into
Group I, Group II and Group III.
Group  I: 40  normal  age and  sex  matched  subjects,
were selected as control group.
Group  II: 40  subjects with  DM  Type  II  without
retinopathy, with duration of diabetes varying from 1
year to 10 years
Group III: We evaluated 40 subjects with DM type II
with  non-proliferatve  retinopathy  with  duration  of
diabetes varying from 1 year to 10 years.
In this study waveform pattern latencies which are P
100 and N 75 and amplitude of VEP were chosen as
the parameters. Visual Evoked Potential used from the
Diopsys Nova Company with the electrodes placement
on the scalp as shown in Fig 2: The diffuse light flash
stimulus  is  rarely  used  due  to  the  high  variability
within and across subjects. The checkerboard patterns
utilize alternate  light and  dark  squares  and  stripes,
respectively.  These  squares  and  stripes  which  are
equal are then presented one at a time via a computer
screen.
Fig  2:  Placement  of  Electrodes,  Scalp  electrodes was
used: 1.Frontal (FP2), 2. Occipital (O2), 3. Grounding
(C2) electrodes
6
Statistical  Analysis: Student‘t’ test  (Independent
sample  t  test")  was  used  for  comparison  of  VEP
between control and diabetes group. One way analysis
of  variance  (ANOVA)  was  used  for  comparing  the
VEP latencies and amplitude with duration of DM and
different level of glycemic control
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Statistical  Analysis: Student‘t’ test  (Independent
sample  t  test")  was  used  for  comparison  of  VEP
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RESULTS
Table 1: Tabulation comprising 40 patients studied over period of 10 years
No.  of
Subjects
Age Duration of DM
Group I 40 49.13 ± 4.52 -
Group II 40 52.70 ± 3.87 4.00  1.76
Group III 40 53.33±4.39 5.47 ± 2.25
Table 2: Comparison of P100 latency, N75 latency of Visual Evoked Potential
No. of Subjects P100 latency (ms) N75 latency (ms) P value
Group I 40 93.82 ± 2 67.46 ± 5.28 < 0.0001*
Group II 40 100.30 ± 4.91 70.76 ± 6.77 < 0.0001*
Group III 40 107.30 ± 4.54 73.81 ± 4.58 < 0.0001*
* The mean difference is significant at the < 0.05 level
Table 3: Comparison of Amplitude of Visual Evoked Potential between the groups
No.  of
Subjects
Amplitude (v) p value
Group I 40 7.52 ± 1.18
<0.0001* Group II 40 3.61 ± 1.24
Group III 40 2.77 ± 1.56
* The mean difference is significant at the < 0.05 level
Table 4: Relationship of various glycemic levels of Diabetes Mellitus with Visual Evoked Potential Latency
(P100).
FBG
(mg/dl)
No.  of
Subjects
P100  latency
(ms)
Amplitude (v) p value
<126 25 97.81 ± 4.25 4.35  2.04
> 0.0001* 126-145 20 103.60  3.07 2.92  1.39
>145 35 108.40  3.70 3.28  1.90
* The mean difference is significant at the < 0.05 level
Table 5: Analysis of P100 Latency in regard with different durations of  Diabetes Mellitus:
Duration (yrs) No. of Subjects P100 latency (ms) Amplitude(ms) p value
<3 28 96.31  6.38 5.54  1.61 < 0.0001*
3 – 7 28 102.29  1.72 3.30  0.98 < 0.0001*
7 – 10 24 105.79  2.92 1.83  0.45 < 0.0001*
* The mean difference is significant at the < 0.05 level
Relationship between duration of diabetes and VEP
latency  and  amplitude: Among  the  subjects,  the
duration of type II diabetes mellitus was found to be
between 1 year and 10 years with a mean of 4.73 ±
1.42 years. The subjects were distributed into 3 groups
based on the duration of diabetes - Subjects > 3 years,
3 – 7 years and < 7 years duration of diabetes mellitus.
Amplitude of VEP and duration of diabetes: The
mean  P100 – N145 amplitude  was  significantly
reduced  with  the  increasing  duration  of  diabetes.
(p.value <0.05)
DISCUSSION
Peripheral and central neuropathy in diabetic patients
can  be  determined  by  Electrophysiological
investigations.  Many  patients  who were  clinically
examined  showed a  decrease of  nerve  conduction
velocity.164
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In  our  study  it  appears  that  pattern  stimulated  VEP
(P100  and  N75  latencies)  in  people  with  diabetes
mellitus shows a distinct prolongation of the latency
period  which  could  be  explained  with  findings  of
Karlica et al.
3
In  our  study  VEP  latencies  and  amplitude  was
correlated  with  duration  of  diabetes  and  we  found
there was a significant changes in VEP. This could be
explained  from  the  basis  of  poor  metabolic  control,
diabetes  duration,  dislipidemia  and  diabetic
nephropathy  and  the  probable  physiological
mechanism could be that VEP abnormalities for both
eyes  is  associated  with  parasympathetic  autonomic
neuropathy  and  the  hyposthetic  form  of  lower-limb
sensory neuropathy.
The mean N75 latency, P100 latency and P100-N145
amplitude were prolonged in those with HbA1c >7%
but the difference were not statistically significant.
CONCLUSION
Visual evoked potentials are useful as a non invasive
investigatory  method  in  establishing  central  nervous
system neuropathy developing in diabetes.
This study clearly shows that changes in VEP may be
detected in diabetics before the onset of retinopathy.
This study also shows that the VEP changes may be
related  to  the  poor control  and  long  duration  of  the
disease, both of which were associated with significant
VEP latency prolongation and decreased amplitude.
Thus VEP measurement is essential for the detection
of  pre  retinopathy  changes  and  has  the  potential  to
reduce DM complications.
Furthermore, it can be performed whenever a patient
with diabetes without retinopathy shows a worsening
of  metabolic  control,  to  evaluate  the  impairment  of
visual  pathways.  It  is  important  to  emphasise  that,
when  tight  metabolic  control  is  achieved,  these
abnormalities  disappear,  suggesting  that  VEP
impairment  is  only  functional  and  completely
reversible.
Future studies should be focused on evaluation of the
time that elapses between the appearance of the first
detectable pathologic electrophysiologic changes and
the  first  ophthalmoscopically  detectable  retinal
changes in patients with DM.
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